L-arginine

Generic Name
L-arginine
Brand Names
Clinimix 2.75/5
Drug Type
Small Molecule
Chemical Formula
-
CAS Number
74-79-3
Unique Ingredient Identifier
-
Associated Conditions
-
Associated Therapies
-

Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients

First Posted Date
2024-05-08
Last Posted Date
2024-05-08
Lead Sponsor
Beni-Suef University
Target Recruit Count
100
Registration Number
NCT06405243
Locations
🇪🇬

Beni-suef university Hospital, Banī Suwayf, Egypt

🇪🇬

Beni-suef university, Banī Suwayf, Egypt

Association Between Postoperative Administration of L-Arginine and CSA-AKI

Recruiting
Conditions
Interventions
First Posted Date
2024-02-08
Last Posted Date
2024-07-24
Lead Sponsor
Xijing Hospital
Target Recruit Count
7000
Registration Number
NCT06248359
Locations
🇨🇳

Xijing Hospital, Xi'an, Shaanxi, China

Effect of the Administration of L-arginine vs. Placebo in Patients Diagnosed With Presbyvestibulopathy.

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2023-07-06
Last Posted Date
2024-02-15
Lead Sponsor
Centro Universitario de Tonalá
Registration Number
NCT05932979
Locations
🇲🇽

CUTonalá, Tonalá, Jalisco, Mexico

L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2022-07-22
Last Posted Date
2023-11-21
Lead Sponsor
Tanta University
Target Recruit Count
50
Registration Number
NCT05470998
Locations
🇪🇬

Tanta university, Tanta, Other (Non U.s.), Egypt

The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication

First Posted Date
2021-03-16
Last Posted Date
2023-11-18
Lead Sponsor
Louis Messina
Target Recruit Count
10
Registration Number
NCT04800692
Locations
🇺🇸

UMASS Memorial Healthcare - University Campus, Worcester, Massachusetts, United States

Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis

First Posted Date
2020-09-02
Last Posted Date
2020-09-02
Lead Sponsor
RenJi Hospital
Target Recruit Count
144
Registration Number
NCT04535427
Locations
🇨🇳

Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

L-arginine Study for Persistent Symptoms of Schizophrenia

First Posted Date
2019-08-13
Last Posted Date
2022-01-20
Lead Sponsor
University of Massachusetts, Worcester
Registration Number
NCT04054973
Locations
🇺🇸

UMass Medical School, Worcester, Massachusetts, United States

L-arginine to Reduce Sympathetic Nerve Activity in CKD Patients

Phase 4
Recruiting
Conditions
Interventions
First Posted Date
2019-06-11
Last Posted Date
2024-01-17
Lead Sponsor
The University of Texas at Arlington
Target Recruit Count
15
Registration Number
NCT03982160
Locations
🇺🇸

University of Delaware, Newark, Delaware, United States

🇺🇸

UT Southwestern, Dallas, Texas, United States

The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction

First Posted Date
2018-09-20
Last Posted Date
2024-06-11
Lead Sponsor
The University of Texas at Arlington
Target Recruit Count
19
Registration Number
NCT03679780
Locations
🇺🇸

Science and Engineering Research and Innovation Building, Arlington, Texas, United States

L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension

Phase 4
Conditions
Interventions
First Posted Date
2018-01-18
Last Posted Date
2018-08-27
Lead Sponsor
Sherief Abd-Elsalam
Target Recruit Count
60
Registration Number
NCT03402191
Locations
🇪🇬

Sherief Abd-Elsalam, Tanta, Egypt

© Copyright 2024. All Rights Reserved by MedPath